Google+ Facebook Twitter Twitter

First blood biomarker for myocarditis

Scientists have identified the first blood biomarker for myocarditis – a cardiac disease that is often misdiagnosed as myocardial infarction.

The team detected the presence of the human homologue of micro RNA miR-721 in the blood of myocarditis patients.

Their results establish the first validated blood marker with high sensitivity and specifity (>90%) for myocarditis.

This will allow clinicians to distinguish between this disease and other cardiomyopathies, such as acute myocardial infarction, myocardial infarction with non-obstructive coronary arteries, and other inflammatory diseases with an autoimmune origin.

Myocarditis is a disease of the heart caused by infection, toxins, drugs, or autoimmune disorders. If untreated, it can progress to potentially fatal dilated cardiomyopathy, requiring heart transplant.

Its prevalence remains uncertain because it is often difficult to achieve a confirmed diagnosis.

Image credit | iStock

Related Articles

Working flexibly across sites

Specialist Biomedical Scientist Kimberly C Lewis gives a guided tour of the clinical biochemistry facilities at Swansea.

Just in time

A look at how and why the blood tubes shortage happened, the implications and if a procurement overhaul is needed.

Type 1 diabetes blood test

A new paper has been published by a global collaborative group on developing a simplified blood test that increases the overall screening efficiency for type 1 diabetes.

Laboratory errors in transfusion: Learning for the laboratory

Anne Lockhart, IBMS representative, and Victoria Tuckley from the Serious Hazards of Transfusion (SHOT) scheme explain their latest annual report.